2.63
0.59 (28.92%)
| Previous Close | 2.04 |
| Open | 2.10 |
| Volume | 50,299 |
| Avg. Volume (3M) | 70,731 |
| Market Cap | 74,225,968 |
| Price / Sales | 8.96 |
| Price / Book | 6.27 |
| 52 Weeks Range | |
| Earnings Date | 9 Nov 2022 |
| Profit Margin | -60.90% |
| Operating Margin (TTM) | -50.68% |
| Diluted EPS (TTM) | -0.460 |
| Quarterly Revenue Growth (YOY) | 5.40% |
| Total Debt/Equity (MRQ) | 37.33% |
| Current Ratio (MRQ) | 5.64 |
| Operating Cash Flow (TTM) | -9.94 M |
| Levered Free Cash Flow (TTM) | -2.06 M |
| Return on Assets (TTM) | -12.26% |
| Return on Equity (TTM) | -28.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | Alpha Teknova, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 1.50 |
|
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 10.95% |
| % Held by Institutions | 82.17% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |